Method for preparing pregabalin

US2021114972A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021114972-A1
Application numberUS-202017112917-A
CountryUS
Kind codeA1
Filing dateDec 4, 2020
Priority dateJun 6, 2018
Publication dateApr 22, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for preparing pregabalin by a biological enzyme method. In particular, the method comprises producing pregabalin B and an R-configuration compound C by using a compound A as a raw material under the action of a biological enzyme; performing configuration inversion of the separated and recovered R-configuration compound C under the action of an isomerase to produce an S-configuration compound D; and producing pregabalin B from the compound D under the action of a biological enzyme

First claim

Opening claim text (preview).

1 . A method for preparing pregabalin comprising: reacting a compound of formula (I) in a first solvent with a biological enzyme to produce a target compound of formula (III) and a by-product of formula (II); reacting the by-product of formula (II) in a second solvent with an isomerase to perform a configuration inversion to produce a compound of formula (IV); reacting the compound of formula (IV) in a third solvent with the biological enzyme to produce the target compound of formula (III); wherein: R 1 and R 2 are independently hydrogen or an alkyl group; and the biological enzyme is a hydrolase. 2 . The method of claim 1 , wherein the hydrolase is a lipase. 3 . The method of claim 2 , wherein the lipase is a mold lipase, a yeast lipase, or a bacterial lipase. 4 . The method of claim 3 , wherein the mold lipase is from a Rhizopus delemar, an Aspergillus niger, a Rhizomucor miehei, or a Gertrichum candidum. 5 . The method of claim 3 , wherein the yeast lipase is from Candida antarctica B, Candida cylindracea, or Rhodoaorula glutinis. 6 . The method of claim 3 , wherein the bacterial lipase is from Burkholderia cepacia, Pseudomonas, or Staphylococcus epidermidis. 7 . The method of claim 1 , wherein the isomerase is an epimerase. 8 . The method of claim 7 , wherein the epimerase is selected from the group consisting of glucose isomerase, sucrose isomerase, D-tagatose 3-epimerase, D-psicose 3-epimerase, cellobiose 2-epimerase and 2-ketogluconate epimerase. 9 . The method of claim 1 , wherein the biological enzyme, the isomerase, or both are in the form of immobilized enzyme particles, enzyme powder, or cells or organelles containing the biological enzyme or the isomerase. 10 . The method of claim 1 , wherein R 1 and R 2 are independently a C 1 -C 4 branched or straight chain alkyl group. 11 . The method of claim 1 , wherein R 1 is H and R 2 is methyl. 12 . The method of claim 1 , wherein the biological enzyme and the compound of formula (I) have a mass ratio of 1:2-1:20; and/or the isomerase and the compound of formula (II) have a mass ratio of 1:1-1:20; and/or the biological enzyme and the compound of formula (IV) have a mass ratio of 1:2-1:20. 12 . The method of claim 1 , wherein the first solvent and the third solvent is water or a miscible system of water and an organic solvent. 13 . The method of claim 1 , wherein the mass-volume ratio of the compound of formula (I) to the first solvent or the compound of formula (IV) to the third solvent is 1 g:10 mL-1 g:50 mL. 14 . The method of claim 1 , wherein the second solvent is an organic solvent. 15 . The method of claim 1 , wherein the mass-volume ratio of the compound of formula (II) to the second solvent is 1 g:10 mL-1 g:50 mL. 16 . The method of claim 1 , wherein the reacting a compound of formula (I), the reacting the by-product of formula (II), and/or the reacting the compound of formula (IV) is at a temperature range from 25° C. to 55° C. 17 . The method of claim 1 , wherein the reacting a compound of formula (I), the reacting the by-product of formula (II), and/or the reacting the compound of formula (IV) is for a time from 5 h to 20 h. 18 . The method of claim 1 further comprising extracting the by-product of formula (II) before the reacting with the isomerase. 19 . The method of claim 18 , wherein the extracting is with a fourth organic solvent selected from the group consisting of toluene, dichloromethane, methyl tert-butyl ether, and ethyl acetate.

Assignees

Inventors

Classifications

  • Triacylglycerol lipase (3.1.1.3) · CPC title

  • Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids · CPC title

  • by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures · CPC title

  • Isomaltulose synthase (5.4.99.11) · CPC title

  • Cellobiose epimerase (5.1.3.11) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021114972A1 cover?
The present invention relates to a method for preparing pregabalin by a biological enzyme method. In particular, the method comprises producing pregabalin B and an R-configuration compound C by using a compound A as a raw material under the action of a biological enzyme; performing configuration inversion of the separated and recovered R-configuration compound C under the action of an isomerase…
Who is the assignee on this patent?
Zhejiang Huahai Pharm Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N9/90. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).